$CETI
Cyber Enviro-Tech, Inc. Stock $ceti

$ceti Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000107997323001630 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue		$13.90K	$58.07K
YoY Change		-76.07%
Cost Of Revenue		$3.709K	$14.81K
YoY Change		-74.96%
Gross Profit		$10.19K	$43.25K
YoY Change		-76.45%
Gross Profit Margin		73.31%	74.49%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$12.65K	$12.67K
YoY Change		-0.21%
% of Gross Profit		124.13%	29.3%
Operating Expenses		$748.0K	$117.4K
YoY Change		537.11%
Operating Profit		-$737.9K	-$73.89K
YoY Change		898.61%
Interest Expense		$146.9K	$162.3K
YoY Change		-9.5%
% of Operating Profit
Other Income/Expense, Net		-$108.2K	-$162.3K
YoY Change		-33.35%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$846.0K	-$236.2K
YoY Change		258.22%
Net Earnings / Revenue		-6087.85%	-406.73%
Basic Earnings Per Share		-$0.01	$0.00
Diluted Earnings Per Share		-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	118.2M shares	118.2M shares	108.7M shares
Diluted Shares Outstanding		120.5M shares	108.7M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$239.4K	$539.2K	$97.74K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$0.00
Prepaid Expenses
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$534.9K	$765.9K
YoY Change	36.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.707M	$3.331M
YoY Change	52.61%
Goodwill
YoY Change
Intangibles	$1.070M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.840M	$4.120M
YoY Change	95.23%
TOTAL ASSETS
Total Short-Term Assets	$534.9K	$765.9K
Total Long-Term Assets	$4.840M	$4.120M
Total Assets	$5.375M	$4.886M
YoY Change	87.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$220.2K	$122.2K
YoY Change	46.97%
Accrued Expenses	$96.62K	$47.11K
YoY Change	1190.2%
Deferred Revenue
YoY Change
Short-Term Debt	$3.269M	$2.500M
YoY Change	285.48%
Long-Term Debt Due	$497.7K	$366.0K
YoY Change	79.26%
Total Short-Term Liabilities	$814.5K	$617.3K
YoY Change	84.84%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$814.5K	$617.3K
Total Long-Term Liabilities
Total Liabilities	$3.900M	$2.786M
YoY Change	285.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.776M	-$4.731M
YoY Change	178.52%
Common Stock	$77.47K	$121.3K
YoY Change	-33.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$66.40K	$66.40K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$1.474M	$2.100M	$1.969M
YoY Change
Total Liabilities & Shareholders Equity	$5.375M	$4.886M
YoY Change	87.15%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$846.0K	-$236.2K
YoY Change	258.22%
Depreciation, Depletion And Amortization	$12.65K	$12.67K
YoY Change	-0.21%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001935092
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2023Q3	CETI	Contingent Liability ContingentLiability		usd
CY2022Q4	CETI	Convertible Note Payable Current ConvertibleNotePayableCurrent		usd
CY2023Q3	us-gaap	Notes Payable NotesPayable		usd
CY2022Q4	CETI	Note Payable Related Party Less Current Maturities NotePayableRelatedPartyLessCurrentMaturities		usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives		usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q3	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability		usd
CY2022Q1	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods		usd
CY2023Q3	CETI	Warrants Granted In Settlement Of Cs To Be Issued WarrantsGrantedInSettlementOfCsToBeIssued		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	CETI	Options Issued For Services OptionsIssuedForServices		usd
	CETI	Warrants Issued For Services WarrantsIssuedForServices		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	CETI	Acquisition Of Licenses From Kam Biotechnology Ltd AcquisitionOfLicensesFromKamBiotechnologyLtd		usd
	CETI	Acquisition Of Licenses From Kam Biotechnology Ltd AcquisitionOfLicensesFromKamBiotechnologyLtd		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	CETI	Repayment Of Notes Payable RepaymentOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	CETI	Stock Issued For Conversion Of Advance On Joint Venture StockIssuedForConversionOfAdvanceOnJointVenture		usd
CY2022Q3	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives		usd
CY2022Q3	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative		usd
CY2022Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet		usd
	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives		usd
	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative		usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet		usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
CY2022	CETI	Changes In Fair Value Inputs And Assumptions Reflected In Income ChangesInFairValueInputsAndAssumptionsReflectedInIncome		usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-267560
	dei	Entity Registrant Name EntityRegistrantName	Cyber Enviro-Tech, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3601702
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6991 E. Camelback Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite D-300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Scottsdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85251
	dei	City Area Code CityAreaCode	(307)
	dei	Local Phone Number LocalPhoneNumber	200-2803
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	118239283	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	539188	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	297349	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	226676	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	95471	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	765864	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	392820	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3330837	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2429035	usd
CY2023Q3	CETI	Texas Railroad Commission Bond TexasRailroadCommissionBond	62537	usd
CY2022Q4	CETI	Texas Railroad Commission Bond TexasRailroadCommissionBond	50000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	726897	usd
CY2023Q3	us-gaap	Assets Assets	4886135	usd
CY2022Q4	us-gaap	Assets Assets	2871855	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	122214	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	149835	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47107	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7489	usd
CY2022Q4	CETI	Contingent Liability ContingentLiability	5700	usd
CY2023Q3	CETI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	82057	usd
CY2022Q4	CETI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	15000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	5255	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	19887	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	338245	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	237613	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	84290	usd
CY2023Q3	CETI	Convertible Note Payable Current ConvertibleNotePayableCurrent	5710	usd
CY2023Q3	CETI	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	22000	usd
CY2022Q4	CETI	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	25000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	617333	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	440637	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	1645	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	183657	usd
CY2023Q3	CETI	Note Payable Related Party Less Current Maturities NotePayableRelatedPartyLessCurrentMaturities	71932	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	116559	usd
CY2023Q3	CETI	Convertible Long Term Note Payable ConvertibleLongTermNotePayable	1980500	usd
CY2022Q4	CETI	Convertible Long Term Note Payable ConvertibleLongTermNotePayable	334202	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2786324	usd
CY2022Q4	us-gaap	Liabilities Liabilities	958496	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	121254283	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	121254283	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	115914283	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	115914283	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	121255	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	115915	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5937382	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4368442	usd
CY2023Q3	CETI	Common Stock To Be Issued CommonStockToBeIssued	1223939	usd
CY2022Q4	CETI	Common Stock To Be Issued CommonStockToBeIssued	52496	usd
CY2023Q3	CETI	Unearned Stock Compensation UnearnedStockCompensation	384891	usd
CY2022Q4	CETI	Unearned Stock Compensation UnearnedStockCompensation	124274	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	66400	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	66400	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4731474	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2432820	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2099811	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1913359	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4886135	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2871855	usd
CY2023Q3	us-gaap	Revenues Revenues	13897	usd
CY2022Q3	us-gaap	Revenues Revenues	58067	usd
	us-gaap	Revenues Revenues	13897	usd
	us-gaap	Revenues Revenues	58067	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3709	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14813	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3709	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14813	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	10188	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	43254	usd
	us-gaap	Gross Profit GrossProfit	10188	usd
	us-gaap	Gross Profit GrossProfit	43254	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	19931	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	27752	usd
	us-gaap	Professional Fees ProfessionalFees	85219	usd
	us-gaap	Professional Fees ProfessionalFees	66493	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	130552	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24189	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	262264	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	76372	usd
CY2023Q3	CETI	Consulting Expense ConsultingExpense	597566	usd
CY2022Q3	CETI	Consulting Expense ConsultingExpense	65202	usd
	CETI	Consulting Expense ConsultingExpense	1734080	usd
	CETI	Consulting Expense ConsultingExpense	218995	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	748049	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	117413	usd
	us-gaap	Operating Expenses OperatingExpenses	2081563	usd
	us-gaap	Operating Expenses OperatingExpenses	361860	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-737861	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-73889	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2071375	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-318606	usd
CY2023Q3	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	35172	usd
	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	84564	usd
	CETI	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	2638153	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13513	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-100371	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-149010	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-3600	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31604	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31604	usd
CY2023Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	49248	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	49248	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	627591	usd
CY2023Q3	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	600	usd
	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	-450	usd
	CETI	Change In Fair Value Of Contingent Liability ChangeInFairValueOfContingentLiability	3031	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	146870	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	162287	usd
	us-gaap	Interest Expense InterestExpense	225966	usd
	us-gaap	Interest Expense InterestExpense	1386384	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-108167	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-162287	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-227279	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1727319	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-846028	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-236176	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2298654	usd
	us-gaap	Net Income Loss NetIncomeLoss	1408713	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120471674	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120471674	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108687787	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108687787	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117689997	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117689997	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107437855	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107437855	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2578885	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2022Q1	CETI	Shares Issued For Conversion Of Advance On Joint Venture SharesIssuedForConversionOfAdvanceOnJointVenture	233983	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	9999	usd
CY2022Q1	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	75800	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1853196	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1779378	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1473471	usd
CY2022Q2	CETI	Book Adjustments Rounding And Fractional Shares BookAdjustmentsRoundingAndFractionalShares	-128	usd
CY2022Q2	CETI	Options Granted For Services OptionsGrantedForServices	4843	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11550	usd
CY2022Q2	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	95699	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-154040	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1431523	usd
CY2022Q3	CETI	Book Adjustments Rounding And Fractional Shares BookAdjustmentsRoundingAndFractionalShares	111	usd
CY2022Q3	CETI	Options Granted For Services OptionsGrantedForServices	5636	usd
CY2022Q3	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	58492	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	709829	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236177	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1969286	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1913359	usd
CY2023Q1	CETI	Common Stock Issued From Prior Periods CommonStockIssuedFromPriorPeriods	-52496	usd
CY2023Q1	CETI	Options Granted For Services OptionsGrantedForServices	5514	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	256384	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	60000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-504083	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1678678	usd
CY2023Q2	CETI	Options Granted For Services OptionsGrantedForServices	5575	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	619679	usd
CY2023Q2	CETI	Shares Issued In Connection With Convertible Notes Payable SharesIssuedInConnectionWithConvertibleNotesPayable	663636	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-948543	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2019025	usd
CY2023Q3	CETI	Options Granted For Service OptionsGrantedForService	5636	usd
CY2023Q3	CETI	Warrants Granted For Services WarrantsGrantedForServices	111805	usd
CY2023Q3	CETI	Conversion Of Contingent Liability ConversionOfContingentLiability	5250	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	300820	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	503303	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-846028	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2099811	usd
	us-gaap	Profit Loss ProfitLoss	-2298654	usd
	us-gaap	Profit Loss ProfitLoss	1408713	usd
	CETI	Changes In Fair Value Of Derivatives ChangesInFairValueOfDerivatives	-84564	usd
	CETI	Changes In Fair Value Of Derivatives ChangesInFairValueOfDerivatives	-2638153	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3600	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-100371	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-149010	usd
	CETI	Options Issued For Services OptionsIssuedForServices	6725	usd
	CETI	Warrants Issued For Services WarrantsIssuedForServices	671805	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	49248	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	627591	usd
	CETI	Changes In Fair Value Of Contingent Liability ChangesInFairValueOfContingentLiability	-5700	usd
	CETI	Changes In Fair Value Of Contingent Liability ChangesInFairValueOfContingentLiability	3031	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	625133	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	32158	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	105749	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1352759	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	70002	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30901	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	143742	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	50677	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27621	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	221338	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15939	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-35877	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1042083	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-154388	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13600	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	957400	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1210148	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-943800	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1210148	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	337876	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	31500	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3232500	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1075000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	153989	usd
	CETI	Repayment Of Notes Payable RepaymentOfNotesPayable	830891	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2217722	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1143500	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	231839	usd
CY2022Q4	us-gaap	Cash Cash	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1305413	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5636	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31862	usd
CY2023Q3	CETI	Unearned Stocks Compensation UnearnedStocksCompensation	384891	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-221036	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	297349	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	318779	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	539188	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97743	usd
	CETI	Stock Issued For Conversion Of Advance On Joint Venture StockIssuedForConversionOfAdvanceOnJointVenture	233983	usd
	CETI	Stock Issued For Conversion Of Convertible Notes Payable And Accrued Interest StockIssuedForConversionOfConvertibleNotesPayableAndAccruedInterest	1166939	usd
	CETI	Stock Issued For Conversion Of Convertible Notes Payable And Accrued Interest StockIssuedForConversionOfConvertibleNotesPayableAndAccruedInterest	2772702	usd
CY2022Q4	CETI	Contingent Liabilities ContingentLiabilities	5700	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zpcm8vrcjgDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zEAO5dszYz1e">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"> </p>
CY2023Q3	us-gaap	Cash Cash	0	usd
	CETI	Impairment Proved Properties ImpairmentProvedProperties	0	usd
	CETI	Impairment Proved Properties ImpairmentProvedProperties	0	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	418261	usd
CY2023Q3	CETI	Railroad Commission Bond Of Texas RailroadCommissionBondOfTexas	50000	usd
CY2023Q2	CETI	Acquired Finite Lived Intangible Assets Residual Value AcquiredFiniteLivedIntangibleAssetsResidualValue	31604	usd
CY2023Q3	CETI	Acquired Finite Lived Intangible Assets Residual Value AcquiredFiniteLivedIntangibleAssetsResidualValue	726896	usd
CY2023Q3	us-gaap	Production Costs Cumulative ProductionCostsCumulative	2332030	usd
CY2022Q4	us-gaap	Production Costs Cumulative ProductionCostsCumulative	1604983	usd
	us-gaap	Impairment Of Oil And Gas Properties ImpairmentOfOilAndGasProperties	0	usd
	us-gaap	Impairment Of Oil And Gas Properties ImpairmentOfOilAndGasProperties	0	usd
	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	0	usd
	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	0	usd
CY2023Q3	us-gaap	Development Costs Cumulative DevelopmentCostsCumulative	0	usd
CY2022Q4	us-gaap	Development Costs Cumulative DevelopmentCostsCumulative	0	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	0	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	0	usd
CY2022Q4	CETI	Unearned Stocks Compensation UnearnedStocksCompensation	124274	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	116559	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	116559	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zwDiEPsV2SIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_z8Mi5xZRgvK3">Concentration of credit risks</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains accounts with financial institutions. All cash in checking accounts is non-interest bearing and is fully secured by the Federal Deposit Insurance Corporation (FDIC). At times, cash balances may exceed the maximum coverage provided by the FDIC on insured depositor accounts. The Company believes it mitigates its risk by depositing its cash and cash equivalents with major financial institutions.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"> </p>
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	365955	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	277613	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	2134489	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	517859	usd
CY2022	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P1Y
	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P0Y11M23D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.4396	pure
CY2021Q1	CETI	Working Interest WorkingInterest	0.1875	pure
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	86947	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58224	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3330837	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2429035	usd
CY2023Q3	us-gaap	Depreciation Depreciation	12646	usd
CY2022Q3	us-gaap	Depreciation Depreciation	12673	usd
	us-gaap	Depreciation Depreciation	38398	usd
	us-gaap	Depreciation Depreciation	30901	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	2607124	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	869500	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	106680	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	74028	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2500444	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	795472	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	179500	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	276000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2151624	usd
CY2023Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	2607124	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1163938	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	10654425	shares
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2070500	usd
CY2023Q3	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives	-18046	usd
CY2023Q3	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative	13513	usd
CY2023Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-31559	usd
	CETI	Embedded Derivative Gain On Embedded Derivatives EmbeddedDerivativeGainOnEmbeddedDerivatives	84564	usd
	us-gaap	Embedded Derivative Loss On Embedded Derivative EmbeddedDerivativeLossOnEmbeddedDerivative	100371	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-15807	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.3338
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.3338
CY2022	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.1690
	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.1680
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	7.3038	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.2327	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	7.3378	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0848	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0844	pure
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	3116734	usd
	CETI	Issuance Of Embedded Derivatives IssuanceOfEmbeddedDerivatives	250371	usd
CY2022	CETI	Issuance Of Embedded Derivatives IssuanceOfEmbeddedDerivatives	396013	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	49248	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3512747	usd
	CETI	Changes In Fair Value Inputs And Assumptions Reflected In Income ChangesInFairValueInputsAndAssumptionsReflectedInIncome	-84564	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	116559	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	CETI	Consulting Service ConsultingService	113725	usd
CY2022Q3	CETI	Consulting Service ConsultingService	346325	usd
	CETI	Consulting Service ConsultingService	62750	usd
	CETI	Consulting Service ConsultingService	265750	usd
CY2022	CETI	Consulting Service ConsultingService	431399	usd
	CETI	Consulting Fees ConsultingFees	90608	usd
CY2022	CETI	Consulting Fees ConsultingFees	194712	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	153989	usd
	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.125	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	CETI	Quoted Market Price QuotedMarketPrice	0.782
CY2023Q3	us-gaap	Share Price SharePrice	0.5765
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0155	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0168	pure
CY2023Q1	CETI	Shares Paid SharesPaid	2000000	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.42
CY2023Q3	CETI	Warrants Received WarrantsReceived	3250000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
	CETI	Loss On Modification Of Consulting Agreement LossOnModificationOfConsultingAgreement	447222	usd
CY2023Q3	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	111805	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	613151	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	343101	usd
	CETI	Less Valuation Allowance LessValuationAllowance	613151	usd
	CETI	Less Valuation Allowance LessValuationAllowance	343301	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1420862	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	510433	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1420862	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	510433	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1420862	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	CETI	Average Sales Price AverageSalesPrice	70.64
CY2022	CETI	Average Sales Price AverageSalesPrice	94.13
	CETI	Average Price Of West Texas Intermediate Oil AveragePriceOfWestTexasIntermediateOil	90.79
	CETI	Recoverable Oil Price RecoverableOilPrice	4000000000.0	usd
	us-gaap	Production Costs ProductionCosts	1000000000.0	usd
	CETI	Recoverable Oil Price Net RecoverableOilPriceNet	3000000000.0	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
ceti-20230930_cal.xml	Edgar Link	unprocessable
0001079973-23-001630-index-headers.html	Edgar Link	pending
0001079973-23-001630-index.html	Edgar Link	pending
0001079973-23-001630.txt	Edgar Link	pending
0001079973-23-001630-xbrl.zip	Edgar Link	pending
ceti-20230930.xsd	Edgar Link	pending
ceti_10q-093023.htm	Edgar Link	pending
ceti-20230930_def.xml	Edgar Link	unprocessable
ceti-20230930_lab.xml	Edgar Link	unprocessable
ceti-20230930_pre.xml	Edgar Link	unprocessable
ceti_10q-093023_htm.xml	Edgar Link	completed
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CETI
Cyber Enviro-Tech, Inc. Stock $ceti

2023 Q4 Form 10-Q Financial Statement

#000107997323001630 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CETI Cyber Enviro-Tech, Inc. Stock $ceti

2023 Q4 Form 10-Q Financial Statement

#000107997323001630 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CETI
Cyber Enviro-Tech, Inc. Stock $ceti